New York, NY -- (SBWIRE) -- 12/19/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: MannKind Corporation (NASDAQ:MNKD), Halcon Resources Corp (NYSE:HK), Dynavax Technologies Corporation (NASDAQ:DVAX), ON Semiconductor Corp (NASDAQ:ONNN)
MannKind Corporation (NASDAQ:MNKD) showed a volume of 3.49 million shares by the end of last trade whereas the average volume of the stock remained 4.29 million shares. The stock opened the session at $4.96 but then moved to $4.96. At that price, the stock showed a positive performance of 0.43%. MannKind Corporation (MannKind) is a development-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. The Company’s product candidate, AFREZZA (insulin human) inhalation powder, is insulin that is in late-stage clinical investigation for the treatment of adults with type I or type II diabetes for the control of hyperglycemia. The AFREZZA inhalation powder is centered on a class of potential of hydrogen (pH)-sensitive organic molecules.
Will MNKD Continue To Move Higher? Find Out Here
Halcon Resources Corp (NYSE:HK) opened the session at $3.81 and closed the session at $3.82. The stock showed a positive performance of 0.79% in previous trading session. Traded with volume of 3.40 million shares in the prior session and the average volume of the stock remained 6.56 million shares. Halcon Resources Corporation (Halcon Resources) is an independent energy company focused on the acquisition, production, exploration and development of onshore liquids-rich oil and natural gas assets in the United States. The Company has oil and natural gas reserves located primarily in Texas, North Dakota, Louisiana, Oklahoma and Montana. On August 1, 2012, the Company acquired GeoResources by merger.
For How Long HK will fight for Profitability? Read This Trend Analysis report
Dynavax Technologies Corporation (NASDAQ:DVAX) opened the session at $1.75 and closed the session at $1.80. The stock showed a positive performance of 2.27% in previous trading session. Traded with volume of 3.30 million shares in the prior session and the average volume of the stock remained 4.97 million shares. The beta of the stock remained 2.75. Dynavax Technologies Corporation (Dynavax) is a clinical-stage biopharmaceutical company, discovers and develops products to prevent and treat infectious and inflammatory diseases. Its product candidate is HEPLISAV, a Phase 3 investigational adult hepatitis B vaccine designed to provide higher and earlier protection with fewer doses than licensed vaccines. The Company’s pipeline of product candidates includes HEPLISAV, its autoimmune program partnered with GlaxoSmithKline (GSK),
Why Should Investors Buy DVAX After The Recent Gain? Just Go Here and Find Out
ON Semiconductor Corp (NASDAQ:ONNN) the stock advanced 1.04% and finished the session at $7.75. Traded with volume of 3.29 million shares in the prior session and the average volume of the stock remained 5.05 million shares. The beta of the stock remained 1.46. ON Semiconductor Corporation (ON Semiconductor) designs, manufactures and markets a portfolio of semiconductor components that address the design needs of electronic systems and products. The Company operates in three segments: Application Products Group, Standard Products Group, and SANYO Semiconductor Products Group. The Company's power management semiconductor components control, convert, protect and monitor the supply of power to the different elements within a variety of electronic devices. The Company’s portfolio of power and signal management, logic,
Will ONNN Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)